Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Anti-GM1 ganglioside antibodies in Parkinson's disease.

Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagalà A, Bastone L, Napoli ID, Caracciolo M, Bonavita S, Di Costanzo A, Gambardella A, Quattrone A.

Acta Neurol Scand. 2002 Jul;106(1):54-7.

PMID:
12067330
2.

[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].

Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.

Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97. French.

4.

Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.

Zaprianova E, Majtényi K, Deleva D, Mikova O, Filchev A, Sultanov B, Kolyovska V, Sultanov E, Christova L, Kmetska X, Georgiev D.

Ideggyogy Sz. 2004 Mar 20;57(3-4):94-9.

PMID:
15133910
5.

ELISA-type titertray assay of IgM anti-GM1 autoantibodies.

Bech E, Jakobsen J, Orntoft TF.

Clin Chem. 1994 Jul;40(7 Pt 1):1331-4.

6.
7.

The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.

Sharma MB, Chaudhry R, Tabassum I, Ahmed NH, Sahu JK, Dhawan B, Kalra V.

J Infect Dev Ctries. 2011 Jul 4;5(6):459-64.

8.

Anti-GM1 antibodies in polyneuropathies of unknown origin.

Finsterer J, Muellbacher W, Halbmayer WM, Fischer M, Mamoli B.

J Clin Pathol. 1996 May;49(5):422-5.

9.

Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.

Adler G, Pacuszka T, Strugalska M, Targońska I, Panasiewicz M, Lewartowska A.

Immunol Lett. 1996 Sep;52(2-3):89-93.

PMID:
8905401
10.

Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.

Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA.

J Neuroimmunol. 2006 Apr;173(1-2):174-9. Epub 2006 Jan 10.

PMID:
16376437
11.

Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease.

Voumvourakis C, Rombos A, Konstantoulakis MM, Segditsa I, Papageorgiou C.

Acta Neurol Scand. 1992 Dec;86(6):599-602.

PMID:
1481647
12.

Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease.

Fiszer U, Fredrikson S, Członkowska A.

J Neurol Sci. 1996 Jul;139(1):66-70.

PMID:
8836974
13.

Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.

Quattrini A, Lorenzetti I, Sciorati C, Corbo M, Previtali SC, Feltri ML, Canal N, Wrabetz L, Nemni R, Clementi E.

J Neuroimmunol. 2001 Mar 1;114(1-2):213-9.

PMID:
11240034
14.

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC.

J Neurol Sci. 2005 Dec 15;239(1):37-44. Epub 2005 Sep 8.

PMID:
16154154
15.

Results of testing for anti-GM1 antibodies.

McCombe PA, Wilson R, Prentice RL.

J Clin Neurosci. 2000 May;7(3):209-12.

PMID:
10833617
16.

Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.

Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I.

Muscle Nerve. 2003 Mar;27(3):302-6.

PMID:
12635116
17.

Relationships between anti-ganglioside antibodies and clinical characteristics of Guillain-Barré syndrome.

Irie S, Saito T, Kanazawa N, Nukazawa T, Ito H, Ogino M, Kowa H.

Intern Med. 1997 Sep;36(9):607-12.

18.

[Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].

Irie S, Saito T, Kanazawa N, Ito H, Kowa H.

Rinsho Shinkeigaku. 1994 May;34(5):454-60. Japanese.

PMID:
7924057
19.

Anti-ganglioside antibodies in peripheral neuropathy.

McCombe PA, Wilson R, Prentice RL.

Clin Exp Neurol. 1992;29:182-8.

PMID:
1343861
20.

Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?

Bartolomei F, Boucraut J, Barrié M, Kok J, Dravet C, Viallat D, Bernard D, Gastaut JL.

Epilepsia. 1996 Oct;37(10):922-6.

PMID:
8822688

Supplemental Content

Support Center